|
1
|
Mossey PA, Little J, Munger RG, Dixon MJ
and Shaw WC: Cleft lip and palate. Lancet. 374:1773–1785. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dixon MJ, Marazita ML, Beaty TH and Murray
JC: Cleft lip and palate: Understanding genetic and environmental
influences. Nat Rev Genet. 12:167–178. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Birnbaum S, Ludwig KU, Reutter H, Herms S,
Steffens M, Rubini M, Baluardo C, Ferrian M, Almeida de Assis N,
Alblas MA, et al: Key susceptibility locus for nonsyndromic cleft
lip with or without cleft palate on chromosome 8q24. Nat Genet.
41:473–477. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Grant SF, Wang K, Zhang H, Glaberson W,
Annaiah K, Kim CE, Bradfield JP, Glessner JT, Thomas KA, Garris M,
et al: A genome-wide association study identifies a locus for
nonsyndromic cleft lip with or without cleft palate on 8q24. J
Pediatr. 155:909–913. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maher B: Personal genomes: The case of the
missing heritability. Nature. 456:18–21. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Roessler E, Belloni E, Gaudenz K, Jay P,
Berta P, Scherer SW, Tsui LC and Muenke M: Mutations in the human
Sonic Hedgehog gene cause holoprosencephaly. Nat Genet. 14:357–360.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rahimov F, Marazita ML, Visel A, Cooper
ME, Hitchler MJ, Rubini M, Domann FE, Govil M, Christensen K, Bille
C, et al: Disruption of an AP-2alpha binding site in an IRF6
enhancer is associated with cleft lip. Nat Genet. 40:1341–1347.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Beaty TH, Murray JC, Marazita ML, Munger
RG, Ruczinski I, Hetmanski JB, Liang KY, Wu T, Murray T, Fallin MD,
et al: A genome-wide association study of cleft lip with and
without cleft palate identifies risk variants near MAFB and ABCA4.
Nat Genet. 42:525–529. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mangold E, Ludwig KU, Birnbaum S, Baluardo
C, Ferrian M, Herms S, Reutter H, de Assis NA, Chawa TA, Mattheisen
M, et al: Genome-wide association study identifies two
susceptibility loci for nonsyndromic cleft lip with or without
cleft palate. Nat Genet. 42:24–26. 2010. View Article : Google Scholar
|
|
10
|
Osoegawa K, Vessere GM, Utami KH, Mansilla
MA, Johnson MK, Riley BM, L'Heureux J, Pfundt R, Staaf J, van der
Vliet WA, et al: Identification of novel candidate genes associated
with cleft lip and palate using array comparative genomic
hybridization. J Med Genet. 45:81–86. 2008. View Article : Google Scholar
|
|
11
|
Mostowska A, Hozyasz KK, Wojcicki P,
Biedziak B, Paradowska P and Jagodzinski PP: Association between
genetic variants of reported candidate genes or regions and risk of
cleft lip with or without cleft palate in the polish population.
Birth Deffects Res A Clin Mol Teratol. 88:538–545. 2010. View Article : Google Scholar
|
|
12
|
Blanton SH, Henry RR, Yuan Q, Mulliken JB,
Stal S, Finnell RH and Hecht JT: Folate pathway and nonsyndromic
cleft lip and palate. Birth Deffects Res A Clin Mol Teratol.
91:50–60. 2011. View Article : Google Scholar
|
|
13
|
Nikopensius T, Jagomägi T, Krjutškov K,
Tammekivi V, Saag M, Prane I, Piekuse L, Akota I, Barkane B,
Krumina A, et al: Genetic variants in COL2A1, COL11A2 and IRF6
contribute risk to nonsyndromic cleft palate. Birth Deffects Res A
Clin Mol Teratol. 88:748–756. 2010. View Article : Google Scholar
|
|
14
|
Greene RM and Pisano MM: Palate
morphogenesis: Current understanding and future directions. Birth
Defects Res C Embryo Today. 90:133–154. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu W, Serrano M, Miguel SS, Ruest LB and
Svoboda KK: Cleft lip and palate genetics and application in early
embryological development. Indian J Plast Surg. 42(Suppl): S35–S50.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wend P, Holland JD, Ziebold U and
Birchmeier W: Wnt signaling in stem and cancer stem cells. Semin
Cell Dev Biol. 21:855–863. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park K, Kim K, Rho SB, Choi K, Kim D, Oh
SH, Park J, Lee SH and Lee JH: Homeobox Msx1 interacts with p53
tumor suppressor and inhibits tumor growth by inducing apoptosis.
Cancer Res. 65:749–757. 2005.PubMed/NCBI
|
|
18
|
Sagorny K, Chapellier M, Laperrousaz B and
Maguer-Satta V: BMP and cancer: The Yin and Yang of stem cells. Med
Sci (Paris). 28:416–422. 2012.In French. View Article : Google Scholar
|
|
19
|
Guan Y, Yao H, Zheng Z, Qiu G and Sun K:
MiR-125b targets BCL3 and suppresses ovarian cancer proliferation.
Int J Cancer. 128:2274–2283. 2011. View Article : Google Scholar
|
|
20
|
Chiquet BT, Blanton SH, Burt A, Ma D, Stal
S, Mulliken JB and Hecht JT: Variation in WNT genes is associated
with non-syndromic cleft lip with or without cleft palate. Hum Mol
Genet. 17:2212–2218. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cardoso ML, Bezerra JF, Oliveira GH,
Soares CD, Oliveira SR, de Souza KS, da Silva HP, Silbiger VN,
Luchessi AD, Fajardo CM, et al: MSX1 gene polymorphisms in
non-syndromic cleft lip and/or palate. Oral Dis. 19:507–512. 2013.
View Article : Google Scholar
|
|
22
|
Mostowska A, Hozyasz KK, Wojcicka K,
Biedziak B and Jagodzinski PP: Polymorphic variants at 10q25.3 and
17q22 loci and the risk of non-syndromic cleft lip and palate in
the polish population. Birth Deffects Res A Clin Mol Teratol.
94:42–46. 2012. View Article : Google Scholar
|
|
23
|
Jagomägi T, Nikopensius T, Krjutškov K,
Tammekivi V, Viltrop T, Saag M and Metspalu A: MTHFR and MSX1
contribute to the risk of nonsyndromic cleft lip/palate. Eur J Oral
Sci. 118:213–220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kobayashi GS, Alvizi L, Sunaga DY,
Francis-West P, Kuta A, Almada BV, Ferreira SG, de Andrade-Lima LC,
Bueno DF, Raposo-Amaral CE, et al: Susceptibility to DNA damage as
a molecular mechanism for non-syndromic cleft lip and palate. PLoS
One. 8:e656772013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wilson CL and Miller CJ: Simpleaffy: A
BioConductor package for affymetrix quality control and data
analysis. Bioinformatics. 21:3683–3685. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hong F, Breitling R, McEntee CW, Wittner
BS, Nemhauser JL and Chory J: RankProd: A bioconductor package for
detecting differentially expressed genes in meta-analysis.
Bioinformatics. 22:2825–2827. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. J Roy Stat Soc B. 57:289–300. 1995.
|
|
29
|
Huang DW, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar :
|
|
30
|
Baolin L and Bo H: HPRD: A high
performance RDF database. Network and Parallel Computing. Li K,
Jesshope C, Jin H and Gaudiot JL: 4672. Springer Berlin Heidelberg;
Germany: pp. 364–374. 2007, View Article : Google Scholar
|
|
31
|
Kohl M, Wiese S and Warscheid B:
Cytoscape: Software for visualization and analysis of biological
networks. Methods Mol Biol. 696:291–303. 2011. View Article : Google Scholar
|
|
32
|
Gong X, Wu R, Zhang Y, Zhao W, Cheng L, Gu
Y, Zhang L, Wang J, Zhu J and Guo Z: Extracting consistent
knowledge from highly inconsistent cancer gene data sources. BMC
Bioinformatics. 11:762010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
van Bokhoven H and McKeon F: Mutations in
the p53 homolog p63: Allele-specific developmental syndromes in
humans. Trends Mol Med. 8:133–139. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Malkin D, Li FP, Strong LC, Fraumeni JF
Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ and Tainsky
MA: Germ line p53 mutations in a familial syndrome of breast
cancer, sarcomas and other neoplasms. Science. 250:1233–1238. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Thomason HA, Zhou H, Kouwenhoven EN, Dotto
GP, Restivo G, Nguyen BC, Little H, Dixon MJ, van Bokhoven H and
Dixon J: Cooperation between the transcription factors p63 and IRF6
is essential to prevent cleft palate in mice. J Clin Invest.
120:1561–1569. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
McGrath JA, Hoeger PH, Christiano AM,
McMillan JR, Mellerio JE, Ashton GH, Dopping-Hepenstal PJ, Lake BD,
Leigh IM, Harper JI and Eady RA: Skin fragility and hypohidrotic
ectodermal dysplasia resulting from ablation of plakophilin 1. Brit
J Dermatol. 140:297–307. 1999. View Article : Google Scholar
|
|
37
|
Fomenkov A, Huang YP, Topaloglu O,
Brechman A, Osada M, Fomenkova T, Yuriditsky E, Trink B, Sidransky
D and Ratovitski E: P63 alpha mutations lead to aberrant splicing
of keratinocyte growth factor receptor in the Hay-Wells syndrome. J
Biol Chem. 278:23906–23914. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dhulipala VC, Welshons WV and Reddy CS:
Inhibition of human embryonic palatal mesenchymal cell cycle by
secalonic acid D: A probable mechanism of its cleft palate
induction. Orthod Craniofac Res. 7:227–236. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ekholm SV and Reed SI: Regulation of G(1)
cyclin-dependent kinases in the mammalian cell cycle. Curr Opin
Cell Biol. 12:676–684. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
DeGregori J: The genetics of the E2F
family of transcription factors: Shared functions and unique roles.
Biochim Biophys Acta. 1602:131–150. 2002.PubMed/NCBI
|
|
41
|
Pierce AM, Schneider-Broussard R,
Gimenez-Conti IB, Russell JL, Conti CJ and Johnson DG: E2F1 has
both oncogenic and tumor-suppressive properties in a transgenic
model. Mol Cell Biol. 19:6408–6414. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kusek JC, Greene RM, Nugent P and Pisano
M: Expression of the E2F family of transcription factors during
murine development. Int J Dev Biol. 44:267–278. 2000.PubMed/NCBI
|
|
43
|
Roymans D and Slegers H:
Phosphatidylinositol 3-kinases in tumor progression. Eur J Biochem.
268:487–498. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Philp AJ, Campbell IG, Leet C, Vincan E,
Rockman SP, Whitehead RH, Thomas RJ and Phillips WA: The
phosphatidylinositol 3′-kinase p85alpha gene is an oncogene in
human ovarian and colon tumors. Cancer Res. 61:7426–7429.
2001.PubMed/NCBI
|
|
45
|
Mizoguchi M, Nutt CL, Mohapatra G and
Louis DN: Genetic alterations of Phosphoinositide 3-kinase subunit
genes in human glioblastomas. Brain Pathol. 14:372–377. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Calogero AE, Soma PF, Giuffrida MC,
Giuffrida D, La Vignera S, Romano C, Castiglione R, Bosco P and
Salemi M: PARP1 and CASP3 gene expression in a patient with
multiple head and neck squamous cell carcinoma and Parkinson
disease. Hum Cell. 26:44–46. 2013. View Article : Google Scholar
|
|
47
|
Coutinho-Camillo CM, Lourenço SV,
Nishimoto IN, Kowalski LP and Soares FA: Caspase expression in oral
squamous cell carcinoma. Head Neck. 33:1191–1198. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Nakao A, Imamura T, Souchelnytskyi S,
Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH,
Miyazono K and ten Dijke P: TGF-beta receptor-mediated signalling
through Smad2, Smad3 and Smad4. EMBO J. 16:5353–5362. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kohama K, Nonaka K, Hosokawa R, Shum L and
Ohishi M: TGF-beta-3 promotes scarless repair of cleft lip in mouse
fetuses. J Dent Res. 81:688–694. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Roberts AB and Sporn MB: Physiological
actions and clinical applications of transforming growth
factor-beta (TGF-beta). Growth factors. 8:1–9. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bruna A, Darken RS, Rojo F, Ocaña A,
Peñuelas S, Arias A, Paris R, Tortosa A, Mora J, Baselga J and
Seoane J: High TGFbeta-Smad activity confers poor prognosis in
glioma patients and promotes cell proliferation depending on the
methylation of the PDGF-B gene. Cancer Cell. 11:147–160. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Seton-Rogers SE, Lu Y, Hines LM, Koundinya
M, LaBaer J, Muthuswamy SK and Brugge JS: Cooperation of the ErbB2
receptor and transforming growth factor beta in induction of
migration and invasion in mammary epithelial cells. Proc Natl Acad
Sci USA. 101:1257–1262. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Friese MA, Wischhusen J, Wick W, Weiler M,
Eisele G, Steinle A and Weller M: RNA interference targeting
transforming growth factor-beta enhances NKG2D-mediated antiglioma
immune response, inhibits glioma cell migration and invasiveness
and abrogates tumorigenicity in vivo. Cancer Res. 64:7596–7603.
2004. View Article : Google Scholar : PubMed/NCBI
|
